Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Severity of SARS-CoV-2 compared to other human coronaviruses in children

Researchers observed that symptom presentation of SARS-CoV-2 infections at the community level was very similar to that of endemic human coronavirus infections.

14 Dec 2021

SARS-CoV-2 patients exhibit high specialized pro-resolving molecule serum levels

In a new study, researchers compared the serum levels of bioactive lipids in a cohort of 50 in-patients who had confirmed symptomatic SARS-CoV-2 infection with that of a control group.

14 Dec 2021

Vaccinated seropositive individuals are able to induce high anti-spike SIgA responses

Results of a new study show that the induction of anti-SARSCoV-2 spike saliva SIgA antibodies after vaccination is independent of the gender or type of vaccine received.

14 Dec 2021

New mRNA vaccine platform provides stronger protection against SARS-CoV-2 delta variant

A group of researchers from various institutions developed a nucleoside-modified mRNA vaccine that encodes the SARS-CoV-2 N protein (mRNA-N) and is formulated in lipid nanoparticles for this investigation (LNP).

14 Dec 2021

Machine learning method for determining impact of mutations in the SARS-CoV-2 RBD on binding and antibody escape

Deep mutational learning (DML) is a technique developed by researchers from multiple institutions that combines experimental yeast display screening of RBD mutagenesis libraries with deep sequencing and machine learning.

14 Dec 2021

Mental health burden experienced in Sweden during COVID-19 pandemic

A new study aimed to determine the mental health burden of adults in Sweden through the data collected in the Omtanke2020 Study between 9th June 2020 and 8th June 2021.

14 Dec 2021

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections.

13 Dec 2021

Omicron variant may strike double vaccinated

Largely, scientists are skeptical that the Omicron variant can infect vaccinated individuals. However, a new study published on the medRxiv* preprint server has conducted neutralization assays using an Omicron isolate obtained from patients residing in the United Kingdom.

13 Dec 2021

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

A new study published on the bioRxiv preprint server has hypothesized that T cell receptors (TCR) repertoire can measure the response to vaccines, as it would identify the TCR of clones that respond to the vaccination.

13 Dec 2021

Combination treatment can provide long remissions for young patients with chronic lymphocytic leukemia

Young patients with chronic lymphocytic leukemia (CLL) can enjoy long remissions on the drug ibrutinib, but must stay on it indefinitely to keep the cancer in remission.

13 Dec 2021

New England research on population immunity and SARS-CoV-2

A new study discusses a model-based reconstruction of SARS-CoV-2 attack rate and population-immunity curves for three New England states.

13 Dec 2021

Novel assay using finger-prick samples provides COVID-19 vaccine efficacy data

Researchers estimate vaccine efficacy over a period post-vaccination using quantitative antibody assay on finger-prick blood samples.

13 Dec 2021

NYU Langone Health performs second successful investigational xenotransplantation procedure

Less than two months after the first breakthrough surgery, NYU Langone Health has performed its second successful investigational xenotransplantation procedure using a genetically engineered pig kidney.

13 Dec 2021

SARS-CoV-2 omicron variant may evade host immune responses

A recent study has demonstrated that the omicron variant of severe acute respiratory syndrome coronavirus 2 has a higher ability to evade antibody-mediated neutralization than other variants of concern.

13 Dec 2021

Third dose of SARS-CoV-2 vaccine increases protection against omicron variant

A new study examines the variation in vaccine effectiveness against virus variants using estimated reductions in neutralizing antibody levels from published studies.

13 Dec 2021

Study suggests pre-existing human common cold coronavirus antibodies hinder SARS-CoV-2 immunity

In this study cohort, SARS-CoV-2 infections were confirmed via the RT-PCR test.

13 Dec 2021

Seasonal coronaviruses may help estimate SARS-CoV-2 reinfection risk

New research suggests that common human coronaviruses, such as those that cause the common cold, could also shed light on the patterns of SARS-CoV-2 reinfection.

13 Dec 2021

Researchers develop a universal SARS-CoV-2 neutralizing antibody

A new study has been published in Frontiers in Immunology, where scientists developed a universal SARS-CoV-2 neutralizing antibody, MG1141A.

13 Dec 2021

MV130 immunotherapy boosts natural and vaccine-induced SARS-CoV-2 immunity in mice

A new mouse study found that intranasal administration of MV130 protected against severe acute respiratory syndrome coronavirus 2.

13 Dec 2021

Cellular properties of SARS-CoV-2 spike protein RBD in virus-infected African green monkey kidney epithelial cells

Researchers from the Biological Defence Programme of Singapore have investigated six of these antibodies.

13 Dec 2021

Antibody News and Research

Further Reading

Severity of SARS-CoV-2 compared to other human coronaviruses in children

SARS-CoV-2 patients exhibit high specialized pro-resolving molecule serum levels

Vaccinated seropositive individuals are able to induce high anti-spike SIgA responses

New mRNA vaccine platform provides stronger protection against SARS-CoV-2 delta variant

Machine learning method for determining impact of mutations in the SARS-CoV-2 RBD on binding and antibody escape

Mental health burden experienced in Sweden during COVID-19 pandemic

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

Omicron variant may strike double vaccinated

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

Combination treatment can provide long remissions for young patients with chronic lymphocytic leukemia

New England research on population immunity and SARS-CoV-2

Novel assay using finger-prick samples provides COVID-19 vaccine efficacy data

NYU Langone Health performs second successful investigational xenotransplantation procedure

SARS-CoV-2 omicron variant may evade host immune responses

Third dose of SARS-CoV-2 vaccine increases protection against omicron variant

Study suggests pre-existing human common cold coronavirus antibodies hinder SARS-CoV-2 immunity

Seasonal coronaviruses may help estimate SARS-CoV-2 reinfection risk

Researchers develop a universal SARS-CoV-2 neutralizing antibody

MV130 immunotherapy boosts natural and vaccine-induced SARS-CoV-2 immunity in mice

Cellular properties of SARS-CoV-2 spike protein RBD in virus-infected African green monkey kidney epithelial cells

Using single B cell screening to boost antibody discovery eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo